title: The Roles of Dopamine and Hypocretin in Reward: A Electroencephalographic Study.
abstract: The proper functioning of the mesolimbic reward system is largely dependent on the neurotransmitter dopamine. Recent evidence suggests that the hypocretin system has significant projections to this reward system. We examined the distinct effects of reduced dopamine or reduced hypocretin levels on reward activity in patients with Parkinson's disease, dopamine deficient, as well as patients with narcolepsy-cataplexy, hypocretin depleted, and healthy controls. Participants performed a simple game-like task while high-density electroencephalography was recorded. Topography and timing of event-related potentials for both reward cue, and reward feedback was examined across the entire dataset. While response to reward cue was similar in all groups, two distinct time points were found to distinguish patients and controls for reward feedback. Around 160 ms both patient groups had reduced ERP amplitude compared to controls. Later at 250 ms, both patient groups also showed a clear event-related potential (ERP), which was absent in controls. The initial differences show that both patient groups show a similar, blunted response to reward delivery. The second potential corresponds to the classic feedback-related negativity (FRN) potential which relies on dopamine activity and reflects reward prediction-error signaling. In particular the mismatch between predicted reward and reward subsequently received was significantly higher in PD compared to NC, independent of reward magnitude and valence. The intermediate FRN response in NC highlights the contribution of hypocretin in reward processing, yet also shows that this is not as detrimental to the reward system as in Parkinson's. Furthermore, the inability to generate accurate predictions in NC may explain why hypocretin deficiency mediates cataplexy triggered by both positive and negative emotions.
authors.affiliation: Department of Sleep Medicine, Clinic Barmelweid, 5017 Aargau, Switzerland.
authors.forename: Armand
authors.initials: A
authors.lastname: Mensen
authors.affiliation: Department of Neurology, University Hospital Zurich, 8006 Zurich, Switzerland.
authors.forename: Rositsa
authors.initials: R
authors.lastname: Poryazova
authors.affiliation: Department of Sleep Medicine, Clinic Barmelweid, 5017 Aargau, Switzerland.
authors.forename: Gordana
authors.initials: G
authors.lastname: Huegli
authors.affiliation: Department of Neurology, University Hospital Zurich, 8006 Zurich, Switzerland.
authors.forename: Christian R
authors.initials: CR
authors.lastname: Baumann
authors.affiliation: Department of Neuroscience, University of Geneva, 1211 Geneva, Switzerland.
authors.forename: Sophie
authors.initials: S
authors.lastname: Schwartz
authors.affiliation: Department of Sleep Medicine, Clinic Barmelweid, 5017 Aargau, Switzerland.
authors.forename: Ramin
authors.initials: R
authors.lastname: Khatami
mesh_terms: D000328:Adult; D000368:Aged; D001519:Behavior; D016022:Case-Control Studies; D002385:Cataplexy / Q000378:metabolism / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology*; D004569:Electroencephalography; D018913:Event-Related Potentials, P300; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009290:Narcolepsy / Q000378:metabolism / Q000503:physiopathology*; D000068797:Orexins / Q000172:deficiency / Q000502:physiology*; D010300:Parkinson Disease / Q000378:metabolism / Q000503:physiopathology*; D015203:Reproducibility of Results; D012201:Reward; D012815:Signal Processing, Computer-Assisted
chemical_list: D000068797:Orexins; D004298:Dopamine